JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.-C.
Right arrow Articles by Reis, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.-C.
Right arrow Articles by Reis, D. J.

Vol. 288, Issue 2, 544-549, February 1999

Agmatine Selectively Blocks the N-Methyl-D-Aspartate Subclass of Glutamate Receptor Channels in Rat Hippocampal Neurons1

Xian-Cheng Yang and Donald J. Reis

Division of Neurobiology, Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York

We investigated in rat hippocampus neurons whether 4-(aminobutyl)guanidine (agmatine), formed by decarboxylation of L-arginine by arginine decarboxylase and metabolized to urea and putrescine, can modulate the function of N-methyl-D-aspartate (NMDA) receptor channels. In cultured hippocampal neurons studied by whole-cell patch clamp, extracellular-applied agmatine produced a voltage- and concentration-dependent block of NMDA but not alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid nor kainate currents. Analysis of the voltage dependence of the block suggests that agmatine binds at a site located within the NMDA channel pore with a dissociation constant of 952 µM at 0 mV and an electric distance of 0.62. We also tested effects of several agmatine analogs. Arcaine (1,4-butyldiguanidine) also produced a similar voltage-dependent block of the NMDA current, whereas putrescine (1,4-butyldiamine) had little effect, suggesting that the guanidine group of agmatine is the active moiety when blocking the NMDA channel. Moreover, spermine (an endogenous polyamine) potentiated the NMDA current even in the presence of blocker agmatine or arcaine, suggesting that the guanidine-containing compounds agmatine and arcaine interact with the NMDA channel at a binding site different from that of spermine. Our results indicate that in hippocampal neurons agmatine selectively modulates the NMDA subclass of glutamate receptor channels mediated by the interaction between the guanidine group and the channel pore. The results support other data that agmatine may function as an endogenous neurotransmitter/neuromodulator in brain.

0022-3565/99/2882-0544$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
C. Courteix, A.-M. Privat, T. Pelissier, A. Hernandez, A. Eschalier, and J. Fialip
Agmatine Induces Antihyperalgesic Effects in Diabetic Rats and a Superadditive Interaction with R( )-3-(2-Carboxypiperazine-4-yl)-propyl-1-phosphonic Acid, a N-Methyl-D-aspartate-Receptor Antagonist
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1237 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D.J. Kim, D.I. Kim, S.K. Lee, S.H. Suh, Y.J. Lee, J. Kim, T.S. Chung, and J.E. Lee
Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: Temporal evolution on perfusion MR imaging and histopathologic findings.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 780 - 785.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. C. Roberts, B. M. Grocholski, K. F. Kitto, and C. A. Fairbanks
Pharmacodynamic and Pharmacokinetic Studies of Agmatine after Spinal Administration in the Mouse
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1226 - 1233.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Babál, M. Ruchko, C. C. Campbell, S. P. Gilmour, J. L. Mitchell, J. W. Olson, and M. N. Gillespie
Regulation of Ornithine Decarboxylase Activity and Polyamine Transport by Agmatine in Rat Pulmonary Artery Endothelial Cells
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 372 - 377.
[Abstract] [Full Text]

Home page
 J CARDIOVASC PHARMACOL THERHome page
S. Greenberg, J. George, Y. Wollman, I. Shapira, S. Laniado, and G. Keren
The Effect of Agmatine Administration on Ischemic-Reperfused Isolated Rat Heart
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 37 - 45.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. A. Fairbanks, K. L. Schreiber, K. L. Brewer, C.-G. Yu, L. S. Stone, K. F. Kitto, H. O. Nguyen, B. M. Grocholski, D. W. Shoeman, L. J. Kehl, et al.
Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury
PNAS, September 12, 2000; 97(19): 10584 - 10589.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
S. Greenberg, A. Finkelstein, J. Gurevich, E. Brazowski, F. Rosenfeld, I. Shapira, J. George, S. Laniado, and G. Keren
The Effect of Agmatine on Ischemic and Nonischemic Isolated Rat Heart
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(3): 151 - 158.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.